Perimeter Awarded US Patent for Expanded OTIS(TM) Technology

TORONTO, ON / ACCESSWIRE / July 30, 2019 / Perimeter Medical Imaging has received additional intellectual property protection for its product, OTIS™, in the form of patent US 10,359,271 titled System and Method for Tissue Differentiation in Imaging. This new patent, which was awarded to the company by the United States Patent and Trademark Office on July 23rd, 2019, is a continuation of its patented technology which dates back to 2012.

The patent covers novel systems and methods for the automated identification of features in optical coherence tomography images (OCT) of tissue and methods to automatically assess the degree of tissue differentiation. Perimeter’s patent portfolio now includes two issued U.S. patents and seven patent applications pending.

“We are pleased to have received this latest patent, which covers a key technology that will allow clinicians to more rapidly assess wide-field OCT images intra-operatively, making the interpretation of the patented OTIS™ imaging easier and more efficient.” said William Rosellini, Perimeter’s Chief Executive Officer. The grant of this patent provides further recognition of the quality of the innovation being carried out by Perimeter’s team.

About Perimeter Medical Imaging, Inc.: Perimeter Medical develops, patents, and commercializes advanced in-procedural medical imaging tools. The OTIS™ platform provides clinicians with real-time, ultra-high resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during the clinical procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system.

Contact:
contact@perimetermed.com
647-360-0302

SOURCE: Perimeter Medical Imaging

View source version on accesswire.com:
https://www.accesswire.com/553407/Perimeter-Awarded-US-Patent-for-Expanded-OTISTM-Technology

Staff

Recent Posts

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

3 hours ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting

Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…

3 hours ago

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…

12 hours ago

AARC Celebrates Introduction of the SOAR Act in the House of Representatives

Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…

15 hours ago

She Is Not Skipping a Beat, and Patients Are Noticing

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2…

15 hours ago